August 13, 2017

AS PROBLEMS GO, THIS ONE DOESN’T SEEM TOO AWFUL: A Cancer Conundrum: Too Many Drug Trials, Too Few Patients. “With the arrival of two revolutionary treatment strategies, immunotherapy and personalized medicine, cancer researchers have found new hope — and a problem that is perhaps unprecedented in medical research. There are too many experimental cancer drugs in too many clinical trials, and not enough patients to test them on.”